How Does Solid-Phase Peptide Synthesis (SPPS) Work?

Every research peptide sold as a lyophilized solid began as a single amino acid chemically anchored to a bead of resin. Solid-phase peptide synthesis, introduced by R. B. Merrifield in 1963 [1], is the method behind nearly all synthetic peptides in the research market. Knowing how it works explains most of what appears on a certificate of analysis: why impurities exist, why purity is harder to reach as sequences lengthen, and why counterions and water are part of the delivered material.

The cycle

The chain is built one residue at a time, from the C-terminus toward the N-terminus. The first amino acid is attached to an insoluble resin bead. Each incoming amino acid carries a temporary protecting group on its amine, so that it can react only once; in the now-standard Fmoc strategy that group is removed by mild base. A cycle has three steps: remove the protecting group from the growing chain, couple the next protected amino acid, and wash away the excess reagents. Because the chain stays attached to the solid bead, washing is a matter of filtration, and that simplicity is what made the method automatable.

Reactive side chains, such as the amine of lysine and the acids of aspartate and glutamate, carry their own more permanent protecting groups throughout the assembly. When the last residue is in place, a strong acid, usually trifluoroacetic acid, cleaves the finished chain from the resin and removes the side-chain protection in the same step.

Why impurities are built in

No coupling reaction is perfectly complete. If each cycle succeeds 99 percent of the time, a 15-residue chain requires 14 couplings and about 87 percent of chains come out full-length; a 43-residue chain requires 42, and the figure falls to about 66 percent. The remainder are mostly deletion sequences, chains missing one residue, along with truncated chains and products of side reactions such as oxidation. These are chemically similar to the target, which is what makes them hard to remove and why they appear as the minor peaks beside the main peak on a chromatogram.

Purification and what it leaves behind

The crude product is purified by preparative reversed-phase HPLC, the same separation principle as the analytical run on a certificate, at larger scale. Fractions containing the target are pooled and freeze-dried. Two things survive this step by design. The acid used in cleavage and in the HPLC mobile phase remains paired with the basic groups of the peptide as a counterion, unless it is deliberately exchanged for another such as acetate. And the freeze-dried solid retains bound water. Both are normal, both add mass that is not peptide, and both are the reason net peptide content is reported separately from purity.

What this means for reading a specification

Three consequences follow. Length drives cost and difficulty: every added residue compounds the yield loss, so a long sequence offered at the price of a short one raises the identity question first. Purity is a statement about the peptide fraction after purification, not about the whole solid. And the identity of a synthetic peptide is established by analysis of the finished material, by mass spectrometry against the theoretical mass, not by the synthesis record, because a synthesis can run to completion and still produce the wrong product.

Frequently asked questions

Why does every synthetic peptide batch contain impurities?

No coupling is perfectly complete. Chains that miss a residue continue to grow, producing deletion sequences that are chemically similar to the target.

Why does trifluoroacetate appear on a certificate?

It is used to cleave the chain from the resin and in the HPLC mobile phase, and remains paired with the basic groups of the peptide as a counterion unless exchanged.

Does the synthesis record prove identity?

No. Identity is established by analysis of the finished material, by mass spectrometry against the theoretical mass.